Promising new tools for HIV prevention and treatment have stimulated global initiatives to ?End the HIV Epidemic? and reach the ?End of AIDS;? however, significant challenges to ending the global HIV epidemic remain. Biomedical advances for prevention and treatment will not reach their full potential without rigorous behavioral and social science research to optimize uptake, adherence, and equitable and effective implementation and scale-up. Thus, we propose a renewed HIV Center for Clinical and Behavioral Studies that expands on our history of conducting interdisciplinary HIV research and leverages new partnerships to maximize the potential of biomedical advances, addressing their availability and acceptability to the most vulnerable populations. The HIV Center is unique among NIMH AIDS Research Centers (ARCs) in being based in New York City (NYC), a continuing US AIDS epicenter in a state that has the greatest number of people living with HIV (PLWH) in the US, including ethnic/racial minority populations coping with extreme economic, health, and social disparities. In 2014, HIV Center investigators and other academicians, providers, advocates, and policy-makers joined the Office of the Governor of New York State (NYS) to develop a NYS Blueprint for Ending the Epidemic (EtE). The Blueprint provides the HIV Center with the unique opportunity to use our home city and state as a ?laboratory? to study implementation of EtE initiatives and apply lessons learned to US and global epidemics. Thus, in the next five years, the HIV Center will be guided by the theme, The Science of Ending the HIV/AIDS Epidemic (EtE): Efficacy to Effectiveness at Scale, and its emphasis on implementation research and research at the intersection of behavioral, social, and biomedical sciences. The HIV Center brings together a cadre of investigators at the forefront of multiple disciplines to address three Specific Aims: (1) to catalyze intervention and implementation science research necessary to achieve EtE goals; (2) to translate research into culturally and structurally competent practice and policy for maximum public health impact; and (3) to increase the capacity of current and future generations of scientists, service providers, and community and policy leaders to create and implement biomedical, behavioral, social, and structural HIV prevention and treatment interventions to meet EtE goals. Our Cores ensure methodological and theoretical rigor, identify and rapidly respond to new trends in the epidemic, support critical research- practice partnerships, and train new scientists. We complement the Administrative and Development Cores with three Research Cores: (1) Statistics, Assessment, and Data Management (StAD) Core, focused on innovative analytic, assessment, and data management strategies; (2) Bio-Behavioral Core, focused on research at the interface of the biomedical and the behavioral and social sciences; and (3) Implementation Science and Health Outcomes (ISHO) Core focused on effective, sustained, and equitable achievement of HIV prevention and care outcomes at scale.
The HIV Center will continue as a global leader in HIV prevention and the fight to improve health outcomes and reduce HIV-related health and social disparities that disproportionately burden the most vulnerable ? women, youth, racial/ethnic and sexual minority populations, and other disenfranchised groups. We will work to meet ?Ending the HIV Epidemic? goals by synergizing institutional and intellectual resources; invigorating our multidisciplinary community of scientists, clinicians, and policy-makers; rigorously training a new generation of scientists; supporting research partnerships with public health policy and practice sectors; and translating transformative NIH-supported HIV/AIDS research into real-world practice and policy. We will apply the lessons learned from our research to improve the health and well being of all affected by the HIV epidemic, regardless of where they reside.
|Winhusen, Theresa; Feaster, Daniel J; Duan, Rui et al. (2018) Baseline Cigarette Smoking Status as a Predictor of Virologic Suppression and CD4 Cell Count During One-Year Follow-Up in Substance Users with Uncontrolled HIV Infection. AIDS Behav 22:2026-2032|
|Meyers, Kathrine; Wu, Yumeng; Qian, Haoyu et al. (2018) Interest in Long-Acting Injectable PrEP in a Cohort of Men Who have Sex with Men in China. AIDS Behav 22:1217-1227|
|Bauermeister, José A; Giguere, R; Leu, C S et al. (2018) Patterns of a Rectal Microbicide Placebo Gel Use in a Preparatory Stage for a Phase I Trial Among Young Men Who Have Sex with Men. AIDS Behav 22:412-420|
|Fogel, Jessica M; Sandfort, Theodorus; Zhang, Yinfeng et al. (2018) Accuracy of Self-Reported HIV Status Among African Men and Transgender Women Who Have Sex with Men Who were Screened for Participation in a Research Study: HPTN 075. AIDS Behav :|
|Davis, Alissa; McCrimmon, Tara; Dasgupta, Anindita et al. (2018) Individual, social, and structural factors affecting antiretroviral therapy adherence among HIV-positive people who inject drugs in Kazakhstan. Int J Drug Policy 62:43-50|
|Carballo-Dieguez, Alex; Giguere, Rebecca; Lentz, Cody et al. (2018) Rectal Douching Practices Associated with Anal Intercourse: Implications for the Development of a Behaviorally Congruent HIV-Prevention Rectal Microbicide Douche. AIDS Behav :|
|Fifield, Jocelyn; O'Sullivan, Lucia; Kelvin, Elizabeth A et al. (2018) Social Support and Violence-prone Relationships as Predictors of Disclosure of HIV Status Among Newly Diagnosed HIV-positive South Africans. AIDS Behav :|
|Wainberg, Milton L; McKinnon, Karen; Norcini-Pala, Andrea et al. (2018) Ending AIDS as a Public Health Threat: Treatment-as-Usual Risk Reduction Services for Persons With Mental Illness in Brazil. Psychiatr Serv 69:483-486|
|Tariq, Shema; Hoffman, Susie; Ramjee, Gita et al. (2018) ""I did not see a need to get tested before, everything was going well with my health"": a qualitative study of HIV-testing decision-making in KwaZulu-Natal, South Africa. AIDS Care 30:32-39|
|Giguere, Rebecca; Brown III, William; Balán, Ivan C et al. (2018) Are participants concerned about privacy and security when using short message service to report product adherence in a rectal microbicide trial? J Am Med Inform Assoc 25:393-400|
Showing the most recent 10 out of 714 publications